The N-methyl-D-aspartate receptor and schizophrenia

Israel Journal of Medical Sciences

Volumn 32, Issue 5, 1996, Pages 275-281

  Strous, R D ^a   Javitt, D C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glycine; N methyl D aspartate; Negative symptoms; Phencyclidine; Schizophrenia

Indexed keywords

DISEASES; DRUG PRODUCTS; NEUROPHYSIOLOGY; PHARMACOKINETICS;

PATHOPHYSIOLOGY; PHENCYCLIDINE; RECEPTOR DISFUNCTION; SCHIZOPHRENIA;

DRUG THERAPY;

DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE;

BRAIN FUNCTION; HUMAN; NEGATIVE SYNDROME; NERVE CELL DIFFERENTIATION; SCHIZOPHRENIA; SHORT SURVEY;

BRAIN; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KETAMINE; MODELS, NEUROLOGICAL; PHENCYCLIDINE; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 0030152822     PISSN: 00212180     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (51)